Utility of neuromelanin-sensitive MRI in the diagnosis of dementia with Lewy bodies
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0309885 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Yuta Inagawa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan. Hauptthemen laut MEDLINE: Lewy Body Disease, Melanins, Magnetic Resonance Imaging, Tomography, Emission-Computed, Single-Photon. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Objective
Dementia with Lewy bodies (DLB) is recognized as the second most common cause of degenerative dementia in older people with Alzheimer’s disease (AD), and distinguishing between these 2 diseases may be challenging in clinical practice. However, accurate differentiation is important because these 2 diseases have different prognoses and require different care. Recently, several studies have reported that neuromelanin-sensitive MRI can detect neurodegeneration in the substantia nigra pars compacta (SNc). DLB patients are considered to demonstrate degeneration and a reduction of dopaminergic neurons in the SNc. Therefore, neuromelanin-sensitive MRI may be useful for the diagnosis of DLB. Therefore, in this study, we aimed to investigate the usefulness of neuromelanin-sensitive MRI in the distinguishing DLB from AD.
Methods
A total of 21 probable DLB and 22 probable AD patients were enrolled. All participants underwent both DaT-SPECT and neuromelanin-sensitive MRI. A combined model of neuromelanin-sensitive MRI and Dopamine transporter single-photon emission computed tomography (DaT-SPECT) was created using logistic regression analysis (forced entry method).
Results
There was no difference in the diagnostic utility of neuromelanin-sensitive MRI and DaT-SPECT in distinguishing DLB from AD. There was no significant correlation between the results of neuromelanin-sensitive MRI and DaT-SPECT in DLB patients. The combination of neuromelanin-sensitive MRI and DaT-SPECT demonstrated higher diagnostic performance in distinguishing between DLB and AD compared with neuromelanin-sensitive MRI alone. Additionally, although the combination of both modalities showed a larger AUC compared with DaT-SPECT alone, the difference was not statistically significant.
Conclusions
Neuromelanin-sensitive MRI may be equally or even more useful than DaT-SPECT in the clinical differentiation of DLB from AD. Furthermore, the combination of neuromelanin-sensitive MRI and DaT-SPECT may be a highly sensitive imaging marker for distinguishing DLB from AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan.
- Department of Radiology, Tokyo Medical University, Tokyo, Japan.
ORCID-Profile: Yuta Inagawa
Zitieren
APA
Inagawa, Y., Inagawa, S., Takenoshita, N., Yamamoto, R., Tsugawa, A., Yoshimura, M., Saito, K., & Shimizu, S. (2024). Utility of neuromelanin-sensitive MRI in the diagnosis of dementia with Lewy bodies. PLOS ONE. https://doi.org/10.1371/journal.pone.0309885
Vancouver
Inagawa Y, Inagawa S, Takenoshita N, Yamamoto R, Tsugawa A, Yoshimura M, et al. Utility of neuromelanin-sensitive MRI in the diagnosis of dementia with Lewy bodies. PLOS ONE. 2024. doi:10.1371/journal.pone.0309885
BibTeX
@article{Inagawa2024,
author = {Inagawa, Yuta and Inagawa, Shoya and Takenoshita, Naoto and Yamamoto, Ryo and Tsugawa, Akito and Yoshimura, Mana and Saito, Kazuhiro and Shimizu, Soichiro},
title = {Utility of neuromelanin-sensitive MRI in the diagnosis of dementia with Lewy bodies},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0309885}
}
EUVIMED